EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Apigenin Protects Hypertensive Intracerebral Hemorrhage by Regulating Trx1 Through Binding to PRDX2

Hao-Chen Xu, Ming Liu, Ying-Ying Sun, Jie-Dan Ping, Qing-Hua Cui, Jing-Zhou Chen iD, Hao Li

Phytotherapy Research · 2026-11 · 40 (11) · 6276-6300

DOI: 10.1002/ptr.70439 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2026-09-01. Written by Hao-Chen Xu and 6 co-authors. Institution: State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Pe…. Major MEDLINE topics: Peroxiredoxins, Thioredoxins, Apigenin, Cerebral Hemorrhage. 53 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Noncommunicable Chronic Diseases-National Science and Technology Major Project, The National Natural Science Foundation of China, The Non-Profit Central Research Institute Fund of Chinese Academy of Medical Sciences.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intracerebral hemorrhage (ICH) remains the most severe stroke subtype with high mortality and disability rates. Although apigenin has shown cerebroprotective potential in preclinical studies, its mechanism of action, particularly in hypertensive ICH, remains poorly understood. This study investigates the molecular pathway through which apigenin confers protection against hypertensive ICH. We employed a hypertensive ICH mouse model treated with varying apigenin doses. Through transcriptomic profiling, molecular docking, surface plasmon resonance (SPR), and pull‐down assay, we identified peroxiredoxin 2 (PRDX2) as a direct target of apigenin. Prdx2 −/− mice and recombinant human thioredoxin 1 (rhTrx1) rescue experiments were utilized to validate the signaling pathway. Histological analysis, western blot, immunofluorescence, and zymography were applied to assess hemorrhage, oxidative stress, inflammation, and extracellular matrix (ECM) remodeling. Apigenin administration significantly reduced ICH incidence, hemorrhage volume, and area while enhancing vascular integrity, independent of blood pressure changes. We identified PRDX2 as a direct binding partner of apigenin, with their interaction stabilizing PRDX2 expression. PRDX2 deficiency abolished apigenin's protective effects and exacerbated oxidative stress, neuroinflammation, and vascular damage. Furthermore, apigenin upregulated Trx1 expression via PRDX2, and rhTrx1 administration rescued the protective phenotype in Prdx2 −/− mice by reducing oxidative damage, inflammatory cell infiltration, and vascular smooth muscle cell apoptosis. Our study elucidates a novel apigenin‐PRDX2‐Trx1 antioxidant signaling pathway that protects against hypertensive ICH through blood pressure‐independent mechanisms. These findings not only provide a mechanistic foundation for developing apigenin‐based therapeutics for cerebrovascular diseases, but also offer novel strategies and entry points for future clinical translation.

Subjects

MeSH terms (MEDLINE)

PeroxiredoxinsThioredoxinsApigeninCerebral HemorrhageAnimalsMiceOxidative StressMaleHumansMice, Inbred C57BLMice, KnockoutDisease Models, AnimalHypertensionSignal TransductionMolecular Docking Simulation

Author keywords

PRDX2Trx1apigeninintracerebral hemorrhageoxidative stress

Substances

PeroxiredoxinsThioredoxinsApigeninTxn1 protein, mouse

Authors and institutions

  • State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • National Health Commission Key Laboratory of Cardiovascular Regenerative Medicine, Fuwai Central-China Hospital, Central-China Branch of National Center for Cardiovascular Diseases, Zhengzhou, China.
  • School of Sports Medicine, Wuhan Institute of Physical Education, Wuhan, Hubei Province, China.

ORCID profiles: Jing-Zhou Chen

Funding

  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • The National Natural Science Foundation of China
  • The Non-Profit Central Research Institute Fund of Chinese Academy of Medical Sciences
  • The National High Level Hospital Clinical Research Funding
  • Henan Cardiovascular Disease Center (Central China Subcenter of National Center for Cardiovascular Diseases)

Cite

APA

Xu, H. C., Liu, M., Sun, Y. Y., Ping, J. D., Cui, Q. H., Chen, J. Z., & Li, H. (2026). Apigenin Protects Hypertensive Intracerebral Hemorrhage by Regulating Trx1 Through Binding to PRDX2. Phytotherapy Research, 40(11), 6276-6300. https://doi.org/10.1002/ptr.70439

Vancouver

Xu HC, Liu M, Sun YY, Ping JD, Cui QH, Chen JZ, et al. Apigenin Protects Hypertensive Intracerebral Hemorrhage by Regulating Trx1 Through Binding to PRDX2. Phytotherapy Research. 2026;40(11):6276-6300. doi:10.1002/ptr.70439

BibTeX
@article{Xu2026,
  author = {Xu, Hao-Chen and Liu, Ming and Sun, Ying-Ying and Ping, Jie-Dan and Cui, Qing-Hua and Chen, Jing-Zhou and Li, Hao},
  title = {Apigenin Protects Hypertensive Intracerebral Hemorrhage by Regulating Trx1 Through Binding to PRDX2},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {11},
  pages = {6276--6300},
  doi = {10.1002/ptr.70439}
}
Start for free →